Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Long-Acting Injection”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT00828958
What this trial is testing

Injection Site Tolerability of Multiple Dose Treatment With Long-acting Injectable Risperidone Administered Via Deltoid Muscle in Chronic Schizophrenia Patients.

Who this might be right for
Schizophrenia
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 53
Early research (Phase 1)Study completedNCT06558643
What this trial is testing

Single Ascending Dose Study to Assess the Safety, Tolerability and Pharmacokinetics of MMV371 LAI in Healthy Participants

Who this might be right for
Malaria,Falciparum
Medicines for Malaria Venture 32
Early research (Phase 1)Study completedNCT05179525
What this trial is testing

Comparative Bioavailability of Risperidone.

Who this might be right for
Schizophrenia
Rovi Pharmaceuticals Laboratories 80
Not applicableEnded earlyNCT00287027
What this trial is testing

Family Perspectives:Treatment of Psychiatric Illnesses With Atypical Long Acting Injectable Antipsychotic Medication

Who this might be right for
Psychotic Disorders
National Alliance on Mental Illness New Hampshire 60
Early research (Phase 1)Looking for participantsNCT07411560
What this trial is testing

A Study Looking at How Weekly Injections of Two Hormones - GIP and Amylin - Affect Stomach-related Side Effects in People Who Are Overweight or Obese

Who this might be right for
OverweightObese
Novo Nordisk A/S 100
Not applicableLooking for participantsNCT07516548
What this trial is testing

Pharmacokinetic Study of Long-acting Antiretrovirals and Contraceptives in HIV

Who this might be right for
HIV InfectionsContraceptionDrug-drug Interaction+2 more
University of Alabama at Birmingham 105
Large-scale testing (Phase 3)Study completedNCT00216580
What this trial is testing

A Pilot Study of the Use of Risperidone Long Acting Injectable in the Treatment of Patients With Recent Onset Psychosis

Who this might be right for
Schizophrenia
Janssen Pharmaceutica N.V., Belgium 50
Early research (Phase 1)WithdrawnNCT05119894
What this trial is testing

A Clinical Pharmacology Trial of Brexpiprazole Long Acting Injectable (LAI) Administered as a Single Dose in Patients With Schizophrenia

Who this might be right for
Schizophrenia
Otsuka Pharmaceutical Co., Ltd.
Not applicableStudy completedNCT00155454
What this trial is testing

Intravitreal Long Acting Gas in the Prevention of Early Postoperative Vitreous Hemorrhage in Diabetic Vitrectomy

Who this might be right for
Diabetes MellitusDiabetic RetinopathyVitreous Hemorrhage
National Taiwan University Hospital 61
Not applicableLooking for participantsNCT06807736
What this trial is testing

PrEPared to Choose (PtC) is an Implementation Study of the Delivery of Cabotegravir Long-acting, an Injectable Pre-exposure Prophylaxis (PrEP) Option for HIV Prevention. Injectable PrEP Will be Offered Alongside Oral and Vaginal Ring PrEP From Within a Real-world Context in Cape Town, South Africa.

Who this might be right for
HIV InfectionSexual and Reproductive Health
Desmond Tutu HIV Foundation 1,800
Testing effectiveness (Phase 2)Study completedNCT00653406
What this trial is testing

A Pharmacokinetic and Safety Study of Risperidone Long Acting Injectable in Schizophrenic Patients

Who this might be right for
Schizophrenia
Janssen Pharmaceutical K.K. 29
Large-scale testing (Phase 3)Study completedNCT04001803
What this trial is testing

Study to Identify and Determine Best Implementation Practices for Injectable Cabotegravir+Rilpivirine in the United States (US)

Who this might be right for
HIV Infections
ViiV Healthcare 115
Post-approval studies (Phase 4)Looking for participantsNCT07218211
What this trial is testing

Enhancing PrEP Uptake and Retention Among Latine TGW and GBM in the South Using Long-Acting Injectable PrEP

Who this might be right for
HIV PreventionHIV Pre-exposure ProphylaxisHIV Prevention Program+2 more
Duke University 100
Not applicableActive Not RecruitingNCT06451341
What this trial is testing

IMplementation of CAB+RPV LA for People With HIV in Non-Metropolitan Areas

Who this might be right for
HIV
University of Nebraska 75
Not applicableLooking for participantsNCT05303337
What this trial is testing

Evolution of HIV Reservoir, Inflammation and Microbiota Footprint of PLWH Switching to Long-acting Injectable Treatment Compared to Patients on Oral Dual or Triple Anti-integrase-based Therapy

Who this might be right for
HIV Infections
Hôpital Européen Marseille 120
Post-approval studies (Phase 4)Ended earlyNCT00256997
What this trial is testing

Risperidone Long-Acting Injection Versus Oral Antipsychotics in Schizophrenia Participants With a History of Being Poorly Compliant With Taking Their Medication

Who this might be right for
Schizophrenia
Janssen-Ortho Inc., Canada 167
Large-scale testing (Phase 3)Study completedNCT02651584
What this trial is testing

Clinical Trial of CAM2038, Long-acting Subcutaneous Buprenorphine Injections for Treatment of Patients With Opioid Dependence

Who this might be right for
Opioid Use Disorders
Braeburn Pharmaceuticals 428
Testing effectiveness (Phase 2)WithdrawnNCT03744663
What this trial is testing

Long Acting Buprenorphine Injection Compared to Sublingual Buprenorphine/Naloxone Films

Who this might be right for
Opioid Use
Wake Forest University Health Sciences
Post-approval studies (Phase 4)Study completedNCT01451736
What this trial is testing

Oral Risperidone Versus Injectable Paliperidone Palmitate for Treating First-Episode Schizophrenia

Who this might be right for
Schizophrenia (Recent-onset)
University of California, Los Angeles 146
Not applicableEnrolling By InvitationNCT07130500
What this trial is testing

Incentives and Long-Acting Injectable Adherence After Involuntary Hospitalization

Who this might be right for
Schizophrenia DisorderSchizoaffective DisorderBipolar Disorder (BD)+1 more
Stanford University 1,000
Next Page